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Discrimination of beta-thalassemia minor and iron deficiency
anemia by screening test for red blood cell indices
Aziz BATEBI1, Abolghasem POURREZA2, Reza ESMAILIAN3

Aim: To assess the state of iron deficiency anemia and thalassemia minor among couples intending to marry at the
Molla Hadi Sabzevari Health Clinic in Isfahan, Iran.
Materials and methods: Couples who intend to marry have to undergo these tests as part of a compulsory countrywide
program. In this study, the red blood cell (RBC) indices among the study population were measured with an electronic
cell counter (Sysmex K800). The survey involved the measurement of 2 RBC indices, mean corpuscular volume (MCV)
and mean corpuscular hemoglobin (MCH), and the results were compared with the England and Fraser, Shine and Lal,
and Mentzer indices.
Results: The study population included 11,900 individuals, of whom 901 were recognized as having hypochromia
(MCH < 32 pg/cell) and microcytosis (MCV < 80 fL). Of these 901 persons, 444 had developed beta-thalassemia, and
457 had iron deficiency anemia or were affected by other causes of microcytosis and hypochromia.
Conclusion: RBC indices and 3 other index components were examined with the screening test. The screening precision
was based on the cut-off point of the hemoglobin A2 scale detected by column chromatography, or by DNA amplification
by polymerase chain reaction. The findings reveal that the England and Fraser index, with a sensitivity level of 87.2%,
is an acceptable discriminator of thalassemic and nonthalassemic patients. All indices functioned more accurately for
men than for women.
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Introduction
Although thalassemic disorders are categorized as hemoglobinopathies, they result mainly from
fluctuations of normal hemoglobin levels during life, being low or high, rather than from the
production of abnormal hemoglobin (1,2).
Thalassemia is the most common type of hemoglobinopathy transmitted by heredity. These
disorders are the result of the existence of an abnormal allele in one or more globin genes. The
decrease or loss of an α or β chain, as 2 types of thalassemia, has unfavorable effects on the production
and the survival of red blood cells (RBCs) and may cause a decrease in the concentration of the
globin chain and of hemoglobin, resulting in microcytosis and hypochromia.
Thalassemia major is a worldwide disease, but it is more common in the Mediterranean region,
the Middle East, the Asian subcontinent, and southeastern Asia, as well as southwestern Europe
and central Africa.
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Iran suffers from a large number of thalassemia
major patients; however, cases of α-thalassemia are
very rare. The gene frequency of β-thalassemia,
however, is high, and varies considerably from area
to area, with the highest rate of more than 10% being
found around the Caspian Sea and the Persian Gulf.
The prevalence of the disease in other areas is between
4% and 8%. In Isfahan, the frequency is about 8% (3).
There are approximately 15,000 patients registered as
having thalassemia major in Iran, but it is estimated
that the real number may be somewhat larger.
Researchers have paid much attention to
differentiating thalassemia minor from the other
types of hypochromic and microcytic anemia,
because other types of hypochromic anemia are
not transferred as a hereditary disorder. There is no
legal prohibition against the marriage of thalassemic
individuals in Iran; the only preventive application
is informing new couples about the possible
consequences of such marriages.
A definitive differential diagnosis between
thalassemia minor and iron deficiency anemia (IDA)
is based on the results of hemoglobin electrophoresis,
serum iron levels, and ferritin calculation (4). A
rather complex algorithm is used for the detection
of thalassemia minor among volunteers who are
intending to get married in Iran. In this process,
detection of hypochromia and microcytosis by the
measurement of RBC indices is a preliminary step.
The Coulter counter is used for the rapid assessment
and measurement of RBC indices (5).
Thalassemia major, like other recessive illnesses,
can be eliminated if the carriers of the disease are
fully detected and treated (6). Iran has pursued such
an objective since 1998 among volunteers applying
for a marriage license.
Governmental and private laboratories equipped
to screen for thalassemia have been recruited into an
accredited national professional laboratory network,
supervised by a national reference laboratory
and directorate for laboratory affairs. There are
corresponding structures at the provincial level.
Laboratory staff members follow national screening
protocols based on international guidelines (6).
The present study was carried out in 2007 at the
Molla Hadi Sabzevari Health Center in Isfahan, as a
provincial section of the entire program.
276

Materials and methods
Sample of the study
The purpose of the study was discrimination between
beta-thalassemia minor (BTM) and IDA among
couples intending to marry that were referred to the
Molla Hadi Sabzevari Clinic in Isfahan, Iran, in 2007.
Of 11,000 individuals (i.e. 5500 couples), 901 persons
(440 females and 461 males) were detected as having
hypochromia and microcytosis in their RBCs, as
defined in the study proposal. Patients were selected
according to the manual of the program.
Methods of diagnosis
For the detection of couples with hypochromia
and microcytosis in their RBCs, 3 well-known
methods of discrimination between BTM and IDA
were employed. England and Fraser in March of
1973, Mentzer in April of 1973, and Shine and Lal
in March of 1977 (7-9) proposed 3 separate indices
for improving the method of diagnosis of microcytic
and hypochromic anemia. These diagnoses are based
primarily on RBC indices obtained via the Coulter
counter analysis.
1. The England and Fraser index is reflected by the
following equation:
(MCV – RBC + (5Hb) + k = ?), where MCV is
mean corpuscular volume and Hb is hemoglobin.
Thalassemia minor is indicated if the result is less
than 0, while values of 0 or greater demonstrate
nonthalassemic anemia (7).
2. The Shine and Lal index is obtained by
multiplying the MCV by the RBC value. If the result
is less than 1530, thalassemia minor is recognized,
but a larger value indicates nonthalassemic anemia
(8).
3. The Mentzer index is obtained when the MCV
is divided by the mean corpuscular hemoglobin
(MCH) value. If the result is equal to or greater than
13, thalassemia minor is recognized; otherwise,
nonthalassemic anemia is indicated (9).
Methods of analysis
The 3 indices mentioned above, with the main index
of the MCV and/or MCH measurements, were
compared within the study population in 2007.
The results of all of the indices were compared for
the amounts of hemoglobin A2 (HbA2). The latter
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was quantified by Hb electrophoresis following
column chromatography, and the polymerase chain
reaction (PCR) was used when the results of the Hb
electrophoresis were inconclusive (10). For the final
conclusion, the specificity and sensitivity of each
index was determined. To be more precise in the
calculations, the kappa coefficient was employed.
The main purpose of these approaches was to set
the priority of one of these methods against the rest,
to be able to utilize these simple indices in the mass
screening process, and to carry out a routine clinical
analysis.
Couples intending to get married were examined
at different stages (6). In all of the stages, the analysis
of RBC values was conducted with a Sysmex K800
Coulter cell counter. Thalassemia minor was
recognized by the microcytosis and hypochromia
of the RBCs using a peripheral blood smear. The
country’s program for thalassemia control indicates
that the cut-off point of the MCV for microcytosis is
less than 80 fL, and that the MCH for hypochromia is
less than 27 pg/cell. HbA2 was measured by column
chromatography using the Helena SAS-MX alkaline
gel Hb kit (Helena Laboratories, Tyne and Wear, UK).

Results
The study population included 440 women and
461 men. The final analysis showed that 444
persons had BTM and the remaining 457 persons
had nonthalassemic causes of hypochromia and
microcytosis such as IDA, chronic diseases, and
rare causes such as lead poisoning and sideroblastic
anemia. However, the country’s program has no
protocol for definite diagnosis of the sicknesses of the
nonthalassemic group. Further studies are necessary
to identify these conditions in detail (11).
Of the 444 patients who were recognized as
having thalassemia minor, 273 were male and 171
female, and the nonthalassemic persons included 188
males and 261 females. The different sex composition
of these 2 groups could be attributed to a higher
prevalence of IDA among women in Isfahan. Table
1 demonstrates the statistical characteristics of the 2
groups of the study.
According to Table 1, while the MCV in
thalassemic patients was in the range of 50.6-78.8
fL, with an average of 66.4 fL, the corresponding
values for nonthalassemics were 67.3-84.5 fL, with an

Table 1. RBC indices among marriage applicants with definite diagnosis of BTM and nonthalassemic anemia referred to the Molla
Hadi Health Center in Isfahan, 2007.
Standard
deviation

Mean

Maximum

Minimum

6.47

66.4

78.8

50.6

Thalassemia minor

4.49

79.0

84.5

67.3

Nonthalassemic

1.77

4/20

1/25

15.3

Thalassemia minor

1.84

25.1

26.8

19.9

Nonthalassemic

1.11

12.6

15.5

10.5

Thalassemia minor

2.29

13.0

17.2

8.9

Nonthalassemic

Type of anemia

0.613

6.16

7.59

4.84

Thalassemia minor

0.57

5.32

6.47

4.26

Nonthalassemic

2.02

10.98

15.48

7.12

Thalassemia minor

1.789

15.03

19.11

11.59

Nonthalassemic

232.87

1359.80

1972.86

774.18

Thalassemia minor

231.77

1988.91

2222.35

1372.92

Nonthalassemic

8.19

11.05

6.06

27.49

Thalassemia minor

9.90

12.49

14.34

20.97

Nonthalassemic

Rate
index
MCV (fL)
MCH (pg/cell)
Hb (g/dL)
RBC (n × 106/μL)
Mentzer; ≥13 = thalassemia minor
Shine & Lal; <1530 = thalassemia minor
England & Fraser; <0 = thalassemia minor

Formulations and cut-off values: England and Fraser index: (MCV – RBC + (5Hb) + k = ?), (<0 = BTM, 0≥ = IDA).
Shine and Lal index: (multiplying MCV by RBC), (<1530 = BTM, ≥1530 = IDA).
Mentzer index: (MCV divided by MCH), (≥13 = BTM, <13 = IDA).
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average of 79 fL. The significant difference (P < 0.001)
between these values indicates that, in each person
whose MCV is lower than the arbitrary microcytic
cut-off point, the type of anemia, either thalassemic
or nonthalassemic, could be recognized easily. This
is why, in some texts, a MCV of less than 60 fL and
a MCH value of less than 20 pg/cell are considered
as indicators of a very low probability of having IDA
and a higher probability of thalassemia minor (12).
The Mann-Whitney test showed a significant
difference between all of the index distributions in
the thalassemic and nonthalassemic groups (P <
0.001). Table 2 presents a summary of the sensitivity,
specificity, positive and negative predictive values
(PPV and NPV, respectively) of indices regarding
sex, and thalassemia minor among all of the patients
with hypochromia and microcytosis.
As indicated in Table 2, none of the indices studied
demonstrated 100% precision in the recognition
of thalassemia minor. In this study, the England
and Fraser and the MCV indices demonstrated
the highest and lowest sensitivity, respectively, and
determined 87.2% and 81.3% of thalassemia minor.
The highest and lowest indices calculated were from
the Shine and Lal and the England and Fraser indices,
which correctly recognized the nonthalassemic cases

at 90.6% and 62.9%, respectively. In addition, Table 2
shows the highest and lowest PPV belonging to the
Shine and Lal index with 89.6% and the England and
Fraser index with 69.5%, respectively.
The Mentzer and MCV indices demonstrated the
highest and lowest NPV, respectively, with 86.5%
and 81.8%. The highest and lowest kappa agreement
coefficients were those obtained with the Shine and
Lal index, at 73.8%, and the England and Fraser
index, at 49.8%, respectively. However, the kappa
agreement coefficient of the MCV index was 0.629.
The difference between the results of all of the indices
mentioned above and the gold standard (HbA2) was
statistically significant (P < 0.001).
The highest prevalence of IDA, and its coincidence
with thalassemia minor among women, is regarded
as one of the main reasons for a reduction in the
accuracy of these indices in the recognition of
thalassemia minor (13).
Sensitivity, PPV, and NPV were considerably
higher among men compared to women. The
specificity of all indices (except England and Fraser)
was also higher among men than among women
(14,15). However, the Shine and Lal NPV index was
found to be somewhat higher among women than
men (women: 85.7, men: 83.4) (16).

Table 2. Comparison of binary classification tests in the diagnosis of thalassemia minor and other causes of hypochromic microcytic
anemia.
Index
Sensitivity

Specificity

Positive predictive value (PPV)

Group

MCV

Mentzer

Shine & Lal

Men

88.6

94.5

86.4

96

Women

69.6

73.1

77.8

73.1

Total

81.3

86.3

83.1

87.2

Men

95.8

93.7

98.9

54.2

Women

73.4

79.2

84.8

68.8

Total

81.7

85.4

90.6

62.9

Men

94.9

95.9

99.2

75.3

Women

62.6

69

76.4

59.8

Total

81.1

85.1

89.6

69.5

85

92.2

83.4

90.3

79.2

82.2

85.7

96

Men
Negative predictive value (NPV)

Kappa agreement coefficient
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England & Fraser

Women
Total

94.9

92.2

86.4

73.1

Men

0.805

0.884

0.83

0.536

Women

0.423

0.517

0.623

0.402

P-value

<0.001

<0.001

<0.001

<0.001
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Conclusion
IDA and BTM are recognized as the most important
causes of hypochromia and microcytosis. In order to
avoid much more expensive, time-consuming, and
complicated procedures for discrimination between
these disorders, researchers attempt to employ either
RBC indices such as MCV, MCH, and red blood cell
distribution width (RDW), or formulas derived from
these indices. This process helps to select appropriate
individuals for more detailed examination.
In the 1970s, to improve the quality of diagnosis
and differentiation between thalassemia and other
causes of microcytosis and hypochromia, a series
of new indices were proposed by such investigators
as England and Fraser (7), Shine and Lal (8), and
Mentzer (9).
The MCV, RBC, and Hb concentrations were
used to determine patients with microcytosis and
for discrimination between IDA and thalassemia by
England and Fraser. This approach worked properly
and precisely. All of the cases, except for 1 out of
72, were easily recognized. The function took the
following form: DF’ = MCV – RBC – (5 × Hb) –
3.4. A positive value indicated iron deficiency and
a negative value indicated thalassemia minor. The
authors noted that this function is not applicable
during pregnancy (7).
Another study, which was held in Turkey by Demir
et al. in December 2002, showed that discrimination
indices (such as those of Mentzer, England and
Fraser, Srivastava, Green and King, and Shine and
Lal), RBC count, RDW, and RDW index showed a
sensitivity and specificity of 100%. Youden’s indices
of RBC count and RDW were the highest, with values
of 82% and 80%, respectively. Of the patients, 90%
and 92% were correctly identified with the RBC and
RDW indices, respectively. It was also demonstrated
that the RBC count and RDW index are the most
reliable discrimination indices for differentiation
between BTM and IDA (17).
In a study by Madan et al. in Delhi in 1999, a
MCV below 80 fL and a MCH value below 27 pg were
found to be very sensitive markers in the detection
of BTM, even in the presence of iron deficiency (P <
0.0001) (18).

In the present study, the above indices were
compared with ordinary RBC index calculations,
including MCH and MCV. RBC index calculation is
a routine method and a primary test of preliminary
diagnosis of hypochromia and microcytosis, which
is now practiced officially for marriage license
applicants. As pointed out above, none of the
indices had 100% precision in the recognition of
thalassemia minor. Nevertheless, they do have a
rather high precision and can help in thalassemia
screening. Meanwhile, the England and Fraser index,
with regard to its higher sensitivity (87.2%), seems
to be an appropriate index for screening. The Shine
and Lal index, with a coefficient of 0.738, has the
highest correlation with final definite diagnosis tests.
Therefore, it can be a useful index for physicians in
their diagnoses. On the whole, it seems that the above
indices that include several factors as catalysts may be
less erroneous than MCV or MCH alone, although
the England and Fraser index has a lower precision
in comparison with MCV. The most important point
in the analysis of these indices is their different
precision for men and women. The results of these
indices seem more reliable for men than for women.
This could be the result of the higher prevalence
of IDA among women than men. Since the
coincidence of IDA and thalassemia minor can cause
a misdiagnosis by these indices, it is suggested that
physicians should not rely entirely on the results
of these indices when they face women who are
suspected to have IDA. By contrast, these indices are
highly reliable in communities with a low prevalence
of IDA and among men.
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